Peg-interferon alpha induces CD56bright natural killer cell mediated reduction of HBsAg in entecavir treated chronic Hepatitis B patients

被引：0
|
作者：
Shi, Aichao [1 ]
Zhang, Xiaoping [1 ]
Xiao, Fang [1 ]
Yan, Weiming [1 ]
Han, Meifang [1 ]
Chen, Tao [1 ]
Ning, Qin [1 ]
机构：
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Wuhan, Hubei, Peoples R China
来源：
HEPATOLOGY | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
912
引用
收藏
页码：487A / 487A
页数：1
相关论文
共 50 条
  • [11] A Potential Functional Cure in Chinese HBeAg-negative Chronic Hepatitis B Patients Treated with Peg-interferon Alpha-2a
    Chen, Xinyue
    Mao, Qianguo
    Xie, Yao
    Dou, Xiaoguang
    Xie, Qing
    Sheng, Jifang
    Gao, Zhiliang
    Zhou, Xiaoling
    Liu, Yingxia
    Zheng, Huanwei
    Zhang, Shuqin
    Li, Shibo
    Zhu, Fusheng
    Xu, Yuqin
    Zhang, Mingxiang
    Hu, Yaoren
    Chen, Xiaoping
    Huang, Yan
    Ren, Hong
    Jia, Jidong
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2019, 7 (03) : 249 - 257
  • [12] Expansion of circulating CD56bright natural killer cells in patients with JAK2-positive chronic myeloproliferative neoplasms during treatment with interferon-α
    Riley, Caroline H.
    Hansen, Morten
    Brimnes, Marie K.
    Hasselbalch, Hans C.
    Bjerrum, Ole W.
    Straten, Per Thor
    Svane, Inge Marie
    Jensen, Morten Krogh
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2015, 94 (03) : 227 - 234
  • [13] Interferon-γ production by tubulointerstitial human CD56bright natural killer cells contributes to renal fibrosis and chronic kidney disease progression
    Law, Becker M. P.
    Wilkinson, Ray
    Wang, Xiangju
    Kildey, Katrina
    Lindner, Mae
    Rist, Melissa J.
    Beagley, Kenneth
    Healy, Helen
    Kassianos, Andrew J.
    KIDNEY INTERNATIONAL, 2017, 92 (01) : 79 - 88
  • [14] The Significance of Serum HBV Pregenomic RNA in Patients with Low HBsAg Chronic Hepatitis B Following Peg-Interferon Alfa Therapy
    Wang, Menglan
    Chen, Youming
    Lin, Bingliang
    Xie, Dongying
    Deng, Hong
    Lin, Chaoshuang
    Xie, Qifeng
    Zhang, Xiaohong
    Gao, Zhiliang
    HEPATOLOGY, 2018, 68 : 333A - 333A
  • [15] Comparative analysis of Peg-Interferon alpha-2b and Lamivudine in the treatment of chronic hepatitis B patients: Preliminary results
    Koliouskas, D
    Sidiropoulos, I
    Masmanidou, M
    Dokas, S
    Ziakas, A
    JOURNAL OF HEPATOLOGY, 2002, 36 : 237 - 238
  • [16] Low pretreatment serum HBsAg level and viral mutations as predictors of response to PEG-interferon alpha-2b therapy in chronic hepatitis B
    Tangkijvanich, Pisit
    Komolmit, Piyawat
    Mahachai, Varocha
    Sa-nguanmoo, Pattaratida
    Theamboonlers, Apiradee
    Poovorawan, Yong
    JOURNAL OF CLINICAL VIROLOGY, 2009, 46 (02) : 117 - 123
  • [17] Peg-interferon alpha add-on Tenofovir disoproxil fumarate achieved more HBsAg loss in HBeAg-positive chronic hepatitis B naive patients
    Li, Jing
    Qu, Lihong
    Sun, Xuehua
    Liu, Yanhong
    Gong, Qiming
    Yu, Demin
    Zhang, Donghua
    Jiang, Jiehong
    Chen, Jia
    Wei, Dong
    Han, Yue
    Gao, Yueqiu
    Zhang, Qin
    She, Weimin
    Chen, Liang
    Zhang, Jiming
    Zhang, Xinxin
    JOURNAL OF VIRAL HEPATITIS, 2021, 28 (10) : 1381 - 1391
  • [18] IMMUNE DRIVERS OF HBsAg LOSS IN HBEAG NEGATIVE CHRONIC HEPATITIS B PATIENTS AFTER STOPPING NUCLEOTIDE ANALOGUE AND ADMINISTRATION OF PEG-INTERFERON
    Islam, Mojahidul
    Kumar, Karan
    Sevak, Jayesh Kumar
    Jindal, Ankur
    Vyas, Ashish Kumar
    Ramakrishna, Gayatri
    Kottilil, Shyam
    Sharma, Manoj K.
    Sarin, Shiv K.
    Trehanpati, Nirupama
    HEPATOLOGY, 2022, 76 : S265 - S265
  • [19] CD27(+) CD56Bright natural killer cells may be involved in spontaneous clearance of acute hepatitis C in HIV-positive patients
    Eisenhardt, Marianne
    Glaessner, Andreas
    Wolter, Franziska
    Kraemer, Benjamin
    Kokordelis, Pavlos
    Nischalke, Hans-Dieter
    Boesecke, Christoph
    Rockstroh, Juergen K.
    Spengler, Ulrich
    Nattermann, Jacob
    AIDS, 2014, 28 (13) : 1879 - 1884
  • [20] HBV RNA in Serum Is an Early Predictor for HBsAg Loss Following Peg-Interferon Treatment for Patients with Hbeag Positive Chronic Hepatitis B
    Farag, Mina
    Van Campenhout, Margo
    van Bommel, Florian
    Pfefferkorn, Maria
    Fischer, Janett
    Deichsel, Danilo
    Boonstra, Andre
    Van Vuuren, Anneke J.
    Berg, Thomas
    Feld, Jordan J.
    Hansen, Bettina E.
    Janssen, Harry L. A.
    HEPATOLOGY, 2018, 68 : 1192A - 1192A
12345